Clinical outcomes of combined aortic root replacement with mitral valve surgery

Tirone E David1, Susan Armstrong, Manjula Maganti

  • 1Division of Cardiovascular Surgery, Toronto General Hospital, Toronto, Ontario, Canada. tirone.david@uhn.on.ca

Insights

Combined aortic root replacement and mitral valve surgery is complex but offers low operative mortality and good long-term results for patients with complex heart conditions.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Surgery
  • Aortic Root Surgery

Background:

  • Combined aortic root replacement and mitral valve surgery addresses complex cardiovascular pathologies.
  • These procedures are often necessary in patients with previous cardiac surgery history.
  • Aortic aneurysms and degenerative mitral valve disease are common indications.

Purpose of the Study:

  • To evaluate operative mortality, morbidity, and long-term outcomes.
  • To assess survival and reoperation rates after combined procedures.
  • To identify predictors of operative mortality.

Main Methods:

  • A cohort of 123 patients underwent combined aortic root replacement and mitral valve surgery.
  • Procedures involved valve preservation or replacement, with additional surgeries in 57% of patients.
  • Mean follow-up was 4.9 years, with complete data collection.

Main Results:

  • Operative mortality was 6.5%, with late mortality at 9.7%.
  • Common complications included mediastinal reexploration (15%) and pacemaker implantation (18%).
  • Survival rates at 1, 5, and 10 years were 90.9%, 86.1%, and 79.3%, respectively; freedom from reoperation was high.

Conclusions:

  • Combined aortic root and mitral valve surgery is a high-morbidity procedure.
  • Operative mortality is acceptable, and long-term outcomes are favorable.
  • Patients experience good functional status and freedom from complications post-surgery.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.